Original Source(s)
Related Content
Weekly HIV Therapy Meets Primary Endpoint
Patients who switched from daily antiretroviral therapy maintained virologic suppression in two phase 3 trials.
July 23, 2026
-
3 min
Patients who switched from daily antiretroviral therapy maintained virologic suppression in two phase 3 trials.
July 23, 2026